The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

Edwards Lifesciences (NYSE: EW) today announced eight-year data highlighting positive long-term outcomes with its proprietary ...

Edwards Lifesciences announced today that it received CE mark approval for its Sapien M3 mitral valve replacement system.